Gilead says it has ramped up production of remdesivir by 50-fold

Gilead Sciences Inc says it has ramped up production of its antiviral remdesivir and expects to produce millions of vials soon enough. The California-based pharmaceutical company announced in a statement on Thursday that it has increased supply by more than 50-fold since January. Officials say they expect to meet ‘real-time global demand’ beginning in October and … Read more

Gilead says it has ramped up production of remdesivir by 50-fold

Gilead Sciences Inc says it has ramped up production of its antiviral remdesivir and expects to produce millions of vials soon enough. The California-based pharmaceutical company announced in a statement on Thursday that it has increased supply by more than 50-fold since January. Officials say they expect to meet ‘real-time global demand’ beginning in October and … Read more

AstraZeneca approaches US rival Gilead to discuss merger

AstraZeneca approaches US rival Gilead Sciences to discuss merger By Daily Mail City & Finance Reporter Published: 21:52 BST, 7 June 2020 | Updated: 21:52 BST, 7 June 2020 In what would be the largest healthcare deal on record, AstraZeneca has approached its US rival Gilead Sciences to discuss a merger.  AstraZeneca, which is listed … Read more

Gilead looks for global partners to help make its experimental coronavirus drug remdesivir

Gilead Sciences Inc says it is planning to work with international partners to boost production of its experimental coronavirus drug remdesivir. On Friday, the US Food and Drug Administration (FDA) issued emergency use authorization for the medication made by the California-based company.  Remdesivir, which was originally developed as an Ebola drug, is given to hospitalized … Read more

Remdesivir trial data ‘offers hope,’ says Gilead CEO

On the heels of an early announcement that coronavirus patients given Gilead’s Ebola drug remdesivir fared better than those who didn’t get the treatment, the company’s CEO, Daniel O’Day, deemed the results a cause for ‘hope at a time when it is badly needed,’ in an open letter obtained by Fox News.   ‘Positive data’ from … Read more

Gilead can make enough remdesivir to treat ‘several million’ next year

Gilead Sciences said that it has capacity to make enough doses of its drug remdesivir for ‘several million treatment courses’ next year in a Thursday press release announcing its first quarter earnings.   ‘As Gilead continues to work with international partners to expand production, Gilead announced it anticipates more than one million treatment courses will be … Read more

Gilead CEO promises to make remdesivir affordable

The antiviral remdesivir has shown promise for treating coronavirus, and the head of the drug’s maker, Gilead Sciences, said he’s committed to ensuring anyone who needs the drug will have access to it.  ‘We’re going to work very closely with the government and with health care systems to make sure that it’s accessible, that it’s … Read more

Remdesivir trial data ‘offers hope,’ says Gilead CEO

On the heels of an early announcement that coronavirus patients given Gilead’s Ebola drug remdesivir fared better than those who didn’t get the treatment, the company’s CEO, Daniel O’Day, deemed the results a cause for ‘hope at a time when it is badly needed,’ in an open letter obtained by Fox News.   ‘Positive data’ from … Read more